NCT04012346

Brief Summary

Alzheimer's disease (AD) has a detrimental impact on cognitive functions. Based on pilot studies results in patients with neurodegenerative brain diseases the investigators aim for promoting the brain plasticity and improving cognition by noninvasive brain stimulation (NIBS) in healthy young, healthy aged and subjects with mild cognitive impairment due to AD. Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and the more-serious decline of dementia. Different new brain targets, cognitive tasks and stimulation protocols will be tested and optimized for specific subject groups. Design of a functional MRI (fMRI) - repetitive transcranial magnetic stimulation (rTMS) - fMRI study will enable us to explore and identify effect of age, presence of the disease and genetic risk factor (APOE4) on repetitive transcranial magnetic stimulation (rTMS)-induced changes in cognition and related brain connectivity/activations. The study results will improve our understanding of healthy and pathological brain aging and will provide novel information about the usefulness of NIBS in specific subject groups. These results will have an important impact on future non-pharmacological treatment strategies.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2018

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 9, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

July 9, 2019

Status Verified

July 1, 2019

Enrollment Period

1.6 years

First QC Date

June 28, 2019

Last Update Submit

July 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual-attention task accuracy and reaction times

    Stroop task will be presented in fMRI

    On the beginning of the study, after completion of week stimulation a two weeks after completion of stimulation sessions.

Secondary Outcomes (1)

  • Resting state measurement

    On the beginning of the study, after completion of week stimulation a two weeks after completion of stimulation sessions.

Study Arms (2)

Active Comparator: MCI patients with real iTBS

ACTIVE COMPARATOR

Patients will receive real iTBS in a week-long sessions.

Device: Transcranial magnetic stimulation

Sham Comparator: MCI patients with sham iTBS

SHAM COMPARATOR

Patients will receive sham iTBS in a week-long sessions.

Device: Transcranial magnetic stimulation

Interventions

Transcranial magnetic stimulation device will be used. Short protocol iTBS will be applied.

Active Comparator: MCI patients with real iTBSSham Comparator: MCI patients with sham iTBS

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • amnestic single or multi-domain mild cognitive impairment patients in accordance with diagnostic criteria (Albert et al., 2011)

You may not qualify if:

  • psychiatric disorders, including major depression, major vascular lesions, and other brain pathologies detected by MRI that might present with cognitive decline
  • a cardio pacemaker or any MRI-incompatible metal in the body
  • epilepsy
  • any diagnosed psychiatric disorder
  • alcohol/drug abuse
  • lack of cooperation
  • presence of dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ceitec Masaryk University

Brno, 62500, Czechia

RECRUITING

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2019

First Posted

July 9, 2019

Study Start

April 30, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

July 9, 2019

Record last verified: 2019-07

Locations